慢性乙型肝炎-话题@MedSci

#慢性乙型肝炎#

119篇内容 | 6569人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1271260, encodeId=566812e12604e, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=J Viral Hepat：定量胶原蛋白参数评估慢性乙型肝炎非进展期肝纤维化，诊断性能提高, objectType=article, longId=122820, objectId=a03f1228200d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a03f1228200d, replyNumber=0, likeNumber=93, createdTime=2017-12-10, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a03f1228200d, moduleTitle=J Viral Hepat：定量胶原蛋白参数评估慢性乙型肝炎非进展期肝纤维化，诊断性能提高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a03f1228200d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271259, encodeId=4b2b12e1259a4, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=SCI REP：循环miR-210和miR-22结合ALT预测慢性乙型肝炎患者进行IFN-α治疗的病毒学应答!, objectType=article, longId=120238, objectId=b0771202389f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b0771202389f, replyNumber=0, likeNumber=91, createdTime=2017-11-17, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b0771202389f, moduleTitle=SCI REP：循环miR-210和miR-22结合ALT预测慢性乙型肝炎患者进行IFN-α治疗的病毒学应答!, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b0771202389f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271258, encodeId=d47d12e125859, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=Gut：慢性乙型肝炎免疫耐受期患者肝细胞癌和死亡风险较高！, objectType=article, longId=119589, objectId=1e70119589cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e70119589cc, replyNumber=0, likeNumber=91, createdTime=2017-11-12, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e70119589cc, moduleTitle=Gut：慢性乙型肝炎免疫耐受期患者肝细胞癌和死亡风险较高！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e70119589cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271257, encodeId=2e1012e1257f1, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=聚乙二醇干扰素α治疗慢性乙型肝炎专家共识, objectType=article, longId=119062, objectId=6d19119062dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d19119062dd, replyNumber=0, likeNumber=77, createdTime=2017-11-08, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d19119062dd, moduleTitle=聚乙二醇干扰素α治疗慢性乙型肝炎专家共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d19119062dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271256, encodeId=7a3512e125614, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=Gut：免疫耐受期慢性乙型肝炎患者肝细胞癌和死亡的高危因素分析！, objectType=article, longId=117169, objectId=6ad711e169f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ad711e169f3, replyNumber=0, likeNumber=68, createdTime=2017-10-24, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ad711e169f3, moduleTitle=Gut：免疫耐受期慢性乙型肝炎患者肝细胞癌和死亡的高危因素分析！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ad711e169f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271255, encodeId=ce5912e125582, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=Antivir Ther：慢性乙型肝炎患者血清细胞因子与趋化因子水平与抗病毒应答相关, objectType=article, longId=114761, objectId=0e41114e61d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e41114e61d6, replyNumber=0, likeNumber=92, createdTime=2017-09-30, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e41114e61d6, moduleTitle=Antivir Ther：慢性乙型肝炎患者血清细胞因子与趋化因子水平与抗病毒应答相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e41114e61d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271254, encodeId=ef6712e12548e, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=Liver Int：慢性乙型肝炎患者肝细胞癌动态风险预测, objectType=article, longId=112473, objectId=9ce61124e3ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ce61124e3ba, replyNumber=0, likeNumber=91, createdTime=2017-09-11, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ce61124e3ba, moduleTitle=Liver Int：慢性乙型肝炎患者肝细胞癌动态风险预测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ce61124e3ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271253, encodeId=bfa512e125301, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=Hepatology：HBeAg阴性的慢性乙型肝炎患者停用口服抗病毒药物后的复发, objectType=article, longId=112444, objectId=1e7611244454, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e7611244454, replyNumber=0, likeNumber=92, createdTime=2017-09-10, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e7611244454, moduleTitle=Hepatology：HBeAg阴性的慢性乙型肝炎患者停用口服抗病毒药物后的复发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e7611244454)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271252, encodeId=08fa12e12528f, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=Am J Gastroenterol：Fibrosis-4指数有助于确定慢性乙型肝炎患者肝癌风险, objectType=article, longId=112248, objectId=66fc112248c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=66fc112248c6, replyNumber=0, likeNumber=89, createdTime=2017-09-09, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=66fc112248c6, moduleTitle=Am J Gastroenterol：Fibrosis-4指数有助于确定慢性乙型肝炎患者肝癌风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=66fc112248c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271251, encodeId=659012e1251c8, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=J Viral Hepat：肝脂肪变性和慢性乙型肝炎相关关系, objectType=article, longId=111835, objectId=463d1118358c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=463d1118358c, replyNumber=0, likeNumber=89, createdTime=2017-09-05, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=463d1118358c, moduleTitle=J Viral Hepat：肝脂肪变性和慢性乙型肝炎相关关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=463d1118358c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271250, encodeId=cac812e125093, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=SCI REP：简单的无创性指标可以预测慢性乙型肝炎患者中的肝细胞癌患者！, objectType=article, longId=110541, objectId=a41811054105, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a41811054105, replyNumber=0, likeNumber=48, createdTime=2017-08-24, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a41811054105, moduleTitle=SCI REP：简单的无创性指标可以预测慢性乙型肝炎患者中的肝细胞癌患者！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a41811054105)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271249, encodeId=987812e12493c, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=突破性免疫疗法将惠及2.5亿慢性乙型肝炎病毒感染者, objectType=article, longId=109002, objectId=16e9109002fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16e9109002fb, replyNumber=0, likeNumber=89, createdTime=2017-08-18, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16e9109002fb, moduleTitle=突破性免疫疗法将惠及2.5亿慢性乙型肝炎病毒感染者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16e9109002fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271248, encodeId=89a912e1248a0, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=Gastroenterol：代谢风险因素对男性慢性乙型肝炎患者肝癌和肝病相关死亡风险的影响:一个大型的队列研究, objectType=article, longId=105863, objectId=d317105863de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d317105863de, replyNumber=0, likeNumber=88, createdTime=2017-07-19, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d317105863de, moduleTitle=Gastroenterol：代谢风险因素对男性慢性乙型肝炎患者肝癌和肝病相关死亡风险的影响:一个大型的队列研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d317105863de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271247, encodeId=61f512e124796, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=SCI REP：血清乙型肝炎核心抗体作为ALT正常的慢性乙型肝炎患者肝脏炎症标志物！, objectType=article, longId=100842, objectId=3c75100842a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c75100842a9, replyNumber=0, likeNumber=102, createdTime=2017-06-07, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c75100842a9, moduleTitle=SCI REP：血清乙型肝炎核心抗体作为ALT正常的慢性乙型肝炎患者肝脏炎症标志物！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c75100842a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271246, encodeId=f42b12e1246df, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=Hepatology：傅阳心课题组在慢性乙型肝炎治疗性疫苗领域获进展, objectType=article, longId=97889, objectId=44019e88990, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=44019e88990, replyNumber=0, likeNumber=98, createdTime=2017-05-06, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=44019e88990, moduleTitle=Hepatology：傅阳心课题组在慢性乙型肝炎治疗性疫苗领域获进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=44019e88990)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271245, encodeId=bca312e1245aa, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=重磅：厦门大学附属中山医院关于粪菌移植治疗慢性乙型肝炎的研究在线发表于国际肝病领域第一期刊Hepatology!, objectType=article, longId=86012, objectId=c7978601254, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7978601254, replyNumber=0, likeNumber=85, createdTime=2016-12-31, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7978601254, moduleTitle=重磅：厦门大学附属中山医院关于粪菌移植治疗慢性乙型肝炎的研究在线发表于国际肝病领域第一期刊Hepatology!, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c7978601254)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271244, encodeId=a21812e124419, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=慢性乙型肝炎核苷（酸）类似物经治患者抗病毒治疗专家共识, objectType=article, longId=83528, objectId=a1f7835282a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a1f7835282a, replyNumber=0, likeNumber=91, createdTime=2016-12-05, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a1f7835282a, moduleTitle=慢性乙型肝炎核苷（酸）类似物经治患者抗病毒治疗专家共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a1f7835282a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271243, encodeId=af7d12e1243c7, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=慢性乙型肝炎核苷（酸）类似物经治患者抗病毒治疗专家共识：2016年更新, objectType=article, longId=83469, objectId=fa3e8346981, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa3e8346981, replyNumber=0, likeNumber=54, createdTime=2016-12-04, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa3e8346981, moduleTitle=慢性乙型肝炎核苷（酸）类似物经治患者抗病毒治疗专家共识：2016年更新, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa3e8346981)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271242, encodeId=00f212e1242eb, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=J Hepatol：慢性乙型肝炎出现肝脏疾病进展和死亡的危险因素研究, objectType=article, longId=82151, objectId=74df8215198, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74df8215198, replyNumber=0, likeNumber=89, createdTime=2016-11-12, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74df8215198, moduleTitle=J Hepatol：慢性乙型肝炎出现肝脏疾病进展和死亡的危险因素研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74df8215198)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271241, encodeId=953012e124157, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=Aliment Pharmacol Ther：抗病毒治疗慢性乙型肝炎，可降低肝癌风险, objectType=article, longId=77221, objectId=516ee7221c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=516ee7221c1, replyNumber=0, likeNumber=51, createdTime=2016-09-13, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=516ee7221c1, moduleTitle=Aliment Pharmacol Ther：抗病毒治疗慢性乙型肝炎，可降低肝癌风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=516ee7221c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

慢性乙型肝炎

2020-05-29

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

J Viral Hepat：定量胶原蛋白参数评估慢性乙型肝炎非进展期肝纤维化，诊断性能提高

2017-12-10

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

SCI REP：循环miR-210和miR-22结合ALT预测慢性乙型肝炎患者进行IFN-α治疗的病毒学应答!

2017-11-17

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

Gut：慢性乙型肝炎免疫耐受期患者肝细胞癌和死亡风险较高！

2017-11-12

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

聚乙二醇干扰素α治疗慢性乙型肝炎专家共识

2017-11-08

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

Gut：免疫耐受期慢性乙型肝炎患者肝细胞癌和死亡的高危因素分析！

2017-10-24

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

Antivir Ther：慢性乙型肝炎患者血清细胞因子与趋化因子水平与抗病毒应答相关

2017-09-30

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

Liver Int：慢性乙型肝炎患者肝细胞癌动态风险预测

2017-09-11

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

Hepatology：HBeAg阴性的慢性乙型肝炎患者停用口服抗病毒药物后的复发

2017-09-10

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

Am J Gastroenterol：Fibrosis-4指数有助于确定慢性乙型肝炎患者肝癌风险

2017-09-09

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

J Viral Hepat：肝脂肪变性和慢性乙型肝炎相关关系

2017-09-05

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

SCI REP：简单的无创性指标可以预测慢性乙型肝炎患者中的肝细胞癌患者！

2017-08-24

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

突破性免疫疗法将惠及2.5亿慢性乙型肝炎病毒感染者

2017-08-18

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

Gastroenterol：代谢风险因素对男性慢性乙型肝炎患者肝癌和肝病相关死亡风险的影响:一个大型的队列研究

2017-07-19

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

SCI REP：血清乙型肝炎核心抗体作为ALT正常的慢性乙型肝炎患者肝脏炎症标志物！

2017-06-07

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

Hepatology：傅阳心课题组在慢性乙型肝炎治疗性疫苗领域获进展

2017-05-06

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

重磅：厦门大学附属中山医院关于粪菌移植治疗慢性乙型肝炎的研究在线发表于国际肝病领域第一期刊Hepatology!

2016-12-31

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

慢性乙型肝炎核苷（酸）类似物经治患者抗病毒治疗专家共识

2016-12-05

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

慢性乙型肝炎核苷（酸）类似物经治患者抗病毒治疗专家共识：2016年更新

2016-12-04

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

J Hepatol：慢性乙型肝炎出现肝脏疾病进展和死亡的危险因素研究

2016-11-12

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

Aliment Pharmacol Ther：抗病毒治疗慢性乙型肝炎，可降低肝癌风险

2016-09-13

科室
- - 订阅+
  - 更多科室
工具
服务